Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: The ECSMOKE trial protocol

BMJ Open

Volumn 9, Issue 5, 2019, Pages

  Berlin, Ivan ^a,b   Dautzenberg, Bertrand ^a   Lehmann, Blandine ^c   Palmyre, Jessica ^c   Liégey, Emmanuelle ^c   De Rycke, Yann ^a   Tubach, Florence ^a,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

controlled; double dummy trial; electronic cigarettes; randomised; smoking cessation; varenicline

Indexed keywords

ANABASINE; CARBON MONOXIDE; NICOTINE; VARENICLINE; NICOTINIC AGENT;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXPIRED AIR; HUMAN; MEDICATION COMPLIANCE; MULTICENTER STUDY; PARALLEL DESIGN; PATIENT COMPLIANCE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING CESSATION; TOBACCO DEPENDENCE; TOBACCO USE; TREATMENT DURATION; URINE LEVEL; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; ELECTRONIC CIGARETTE; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; RESEARCH DESIGN; SMOKING CESSATION; TREATMENT OUTCOME; VARENICLINE; YOUNG ADULT;

EID: 85066840323     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2018-028832     Document Type: Article

References (47)

1. WHO. Tobacco Free Initiative. http://www.who.int/tobacco/health-priority/en/(Accessed 10 Sep 2018).
2. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.
3. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341-50.
4. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med 2014;370:60-8.
5. Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA 2014;311:164-71.
6. Official Journal of the European Union. Directive 2017/40/EU of the European Parliament and of the council of 3 April 2014. http://ec. europa. eu/health//sites/health/files/tobacco/docs/dir-201440-en.pdf (Accessed 10 Sep 2018).
7. Ordonnance n 2016-623 du 19 mai 2016 portant transposition de la directive 2014/40/UE sur la fabrication, la présentation et la vente des produits du tabac et des produits connexes. 2014 https://www. legifrance. gouv. fr/eli/ordonnance/2016/5/19/AFSP1610773R/jo/texte (Accessed 10 Sep 2018).
8. Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study. Ann Intern Med 2017;166:390-400.
9. The National Academies of Sciences, Engineering, Medicine. Public health consequences of e-cigarettes. 2018 http://nationalacademies. org/hmd/reports/2018/public-health-consequences-of-e-cigarettes. aspx (Accessed 10 Sep 2018).
10. Farsalinos KE, Spyrou A, Stefopoulos C, et al. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naive users (smokers). Sci Rep 2015;5:11269.
11. D'Ruiz CD, Graff DW, Yan XS. Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes. BMC Public Health 2015;15:991.
12. Wagener TL, Floyd EL, Stepanov I, et al. Have combustible cigarettes met their match The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control 2017;26:e23-e28.
13. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010;19:98-103.
14. Vansickel AR, Cobb CO, Weaver MF, et al. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010;19:1945-53.
15. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013;15:267-70.
16. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology 2014;231:401-7.
17. El Dib R, Suzumura EA, Akl EA, et al. Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and metaanalysis. BMJ Open 2017;7:e012680.
18. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in realworld and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016;4:116-28.
19. Weaver SR, Huang J, Pechacek TF, et al. Are electronic nicotine delivery systems helping cigarette smokers quit Evidence from a prospective cohort study of U.S. adult smokers, 2015-2016. PLoS One 2018;13:e0198047.
20. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382:1629-37.
21. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8:e66317.
22. McRobbie H, Bullen C, Hartman-Boyce J, et al. Electronic cigarettes for smoking cessation and reduction. Review. The Cochrane Library 2014;12:CD010216.
23. Hartmann-Boyce J, McRobbie H, Bullen C, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2016;9:CD010216.
24. Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med 2019;380:629-37.
25. Bernstein SL. Electronic cigarettes: more light, less heat needed. Lancet Respir Med 2016;4:85-7.
26. Soar K, Kimber C, McRobbie H, et al. Nicotine absorption from e-cigarettes over 12 months. Addictive Behaviors published online on 2018;19.
27. Berlin I, Jacob N, Coudert M, et al. Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS trial-a randomized study in smokers with medical comorbidities. Addiction 2011;106:833-43.
28. Berlin I, Grangé G, Jacob N, et al. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014;348:g1622.
29. Dawkins LE, Kimber CF, Doig M, et al. Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects. Psychopharmacology 2016;233:2933-41.
30. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 2016;387:2507-20.
31. Cahill K, Lindson-Hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2016;5:CD006103.
32. Cahill K, Stevens S, Perera R, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013;5:CD009329.
33. Haute Autorité de Santé. Arrêt de la consommation de tabac : du dépistage individuel au mentien de l'abstinence en premier recours. https://www. has-sante. fr/portail/jcms/c-1718021/fr/arret-de-la-consommation-de-tabac-du-depistage-individuel-aumaintien-de-labstinence-en-premier-recours (Accessed 11 Sep 2018).
34. Berlin I, Singleton EG, Heishman SJ. Validity of the 12-item French version of the tobacco craving questionnaire in treatment-seeking smokers. Nicotine Tob Res 2010;12:500-7.
35. University of Vermont. Minnesota tobacco withdrawal scale. http://www. med. uvm. edu/behaviorandhealth/research/minnesota-tobaccowithdrawal-scale (Accessed on 11 September 2018).
36. Marclay F, Saugy M. Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatographytandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players. J Chromatogr A 2010;1217:7528-38.
37. Société Française d'Alcoologie. Mésusage de l'alcool. Dépistage, diagnostic et traitement. https://www. sfalcoologie. asso. fr/download/RBP2014-SFA-Mesusage-AA.pdf (Accessed 11 Sep 2018).
38. Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med 2000;160:1977-89.
39. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984;252:1905-7.
40. Santé Publique France. Alcool et médecine générale. Recommandations cliniques pour le repérage précoce et les interventions brèves. http://inpes. santepubliquefrance. fr/CFESBases/catalogue/pdf/1146.pdf (Accessed 11 Sep 2018).
41. Casagrande JT, Pike MC, Smith PG. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics 1978;34:483-6.
42. Dunnett CW, Gent M. Significance testing to establish equivalence between treatments, with special reference to data in the form of 2X2 tables. Biometrics 1977;33:593-602.
43. Code de la Santé publique. Article R1123-46. 2016 https://www. legifrance. gouv. fr/affichCodeArticle. do cidTexte=LEGITEXT000006072665& idArticle=LEGIARTI000006908425& dateTexte=& categorieLien=cid (Accessed 12 Sep 2018).
44. Code de la santé publique. Article L1123. 2018 https://www. legifrance. gouv. fr/affichCodeArticle. do; jsessionid=789B 43C3 388E 2FBF 44B1 4018 4C1AEB33. tplgfr36s-1 idArticle=LEGIARTI000037090338& cidTexte=LEGITEXT000006072665& categorieLien=id& dateTexte=(Accessed 12 Sep 2018).
45. Code pénal. Article 226-13. 2002 https://www. legifrance. gouv. fr/affichCodeArticle. do cidTexte=LEGITEXT000006070719& idArticle=LEGIARTI000006417944& dateTexte& categorieLien=cid (Accessed 12 Sep 2018).
46. Code pénal. Article 226-14. 2015 https://www. legifrance. gouv. fr/affichCodeArticle. do cidTexte=LEGITEXT000006070719& idArticle=LEGIARTI000006417946& dateTexte=& categorieLien=cid (Accessed 12 Sep 2018).
47. International committee of Medical Journal Editors. Defining the role of authors and contributors http://www. icmje. org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-andcontributors. html (Accessed on 12 September 2018).